Clinical Trials in Arizona

Showing 5801-5820 of 12,706 trials

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

NCT01416428

The purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.

Multiple MyelomaWaldenstrom Macroglobulinemia

Amgen210 participantsStarted Oct 2011

Scottsdale, Arizona, United States • Salinas, California, United States • Denver, Colorado, United States +16 more locations

COMPLETEDPhase 231 miles

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT04051944

The purpose of the study is to assess long-term safety and tolerability of weekly doses of rozanolixizumab in subjects with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

UCB Biopharma SRL21 participantsStarted Aug 2019

Scottsdale, Arizona, United States • Augusta, Georgia, United States • Charlotte, North Carolina, United States +11 more locations

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Find Trials by Condition in Arizona

Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®)

Electrophysiological Recordings of Deep Brain Stimulation in the Basal Ganglia

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Effect of Sotagliflozin on Cardiovascular Events in Participants With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial)

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

Randomized, Double-Blind, Placebo-Controlled Trial, Followed by Single-Arm Treatment of PRO 140

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)

Blepharospasm Patient Survey for Patients With Blepharospasm

Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)

Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell Disease